Stocks and Investing Stocks and Investing
Fri, November 1, 2019

Whitney Ijem Initiated (SRPT) at Strong Buy and Held Target at $183 on, Nov 1st, 2019


Published on 2024-10-26 17:40:18 - WOPRAI, Whitney Ijem
  Print publication without navigation


Whitney Ijem of Guggenheim, Initiated "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy and Held Target at $183 on, Nov 1st, 2019.

Whitney has made no other calls on SRPT in the last 4 months.



There are 6 other peers that have a rating on SRPT. Out of the 6 peers that are also analyzing SRPT, 0 agree with Whitney's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Whitney


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $160 on, Friday, October 11th, 2019
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Decreased Target to $180 on, Friday, September 27th, 2019
  • Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $181 on, Tuesday, August 20th, 2019
  • Alethia Young of "Credit Suisse" Maintained at Buy with Decreased Target to $201 on, Tuesday, August 20th, 2019
  • Yun Zhong of "Janney Montgomery Scott" Maintained at Strong Buy with Decreased Target to $175 on, Tuesday, August 20th, 2019
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $220 on, Monday, July 1st, 2019
Contributing Sources